Randomized phase III trial of paclitaxel/carboplatin (PC) versus cisplatin/irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary: A Japanese ...

Ovarian cancer is often advanced at the time of diagnosis. Debulking is a surgical procedure that may prevent or delay disease progression. Debulking is a type of surgery that removes as many ovarian ...

—This study explores factors associated with complications and survival among women with epithelial ovarian cancer who undergo primary debulking surgery. Reviewed by Vrunda Bhavsar Desai, MD, FACOG, ...

December 23, 2008 — In the treatment of advanced ovarian cancer, neoadjuvant chemotherapy before surgical debulking may be the new standard of care — especially in countries where the scheduling of a ...

Improved overall survival for patients with advanced ovarian, tubal, and primary peritoneal carcinoma as a result of a change in surgical approach: A follow-up study No significant financial ...

Debulking surgery is generally the next step after neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer, but there has been controversy as to whether women should undergo a ...

Neoadjuvant chemotherapy with interval debulking surgery is associated with higher complete gross resection rates and lower postoperative mortality in advanced epithelial ovarian cancer. The use of ...

Interval debulking surgery, or IDS, is a way to treat advanced – meaning stage III or IV – ovarian cancer when primary surgery isn’t possible. IDS also can be performed as a secondary surgery when ...

Significant disparities exist in the adoption of minimally invasive interval debulking surgery for advanced ovarian cancer, with gaps potentially widening as the procedure becomes more common.